INO-4500
LSV-002
Phase 1 small_molecule completed
Quick answer
INO-4500 for Lassa Fever is a Phase 1 program (small_molecule) at INOVIO PHARMACEUTICALS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- INOVIO PHARMACEUTICALS, INC.
- Indication
- Lassa Fever
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed